46
www.fetalmedicinebarcelona.org / UPDATE ON DIAGNOSIS AND MANAGEMENT OF FETAL GROWTH RESTRICTION Eduard Gratacos Center for Maternal-Fetal Medicine and Neonatology Hospital Clinic & Hospital Sant Joan de Deu - University de Barcelona www.fetalmedicinebarcelona.org

UPDATE ON DIAGNOSIS AND MANAGEMENT OF FETAL GROWTH · PDF fileupdate on diagnosis and management of fetal growth restriction ... placental disease hypoxia acidosis serious injury death

Embed Size (px)

Citation preview

www.fetalmedicinebarcelona.org/

UPDATE ON DIAGNOSIS AND MANAGEMENT OF

FETAL GROWTH RESTRICTIONEduard Gratacos

Center for Maternal-Fetal Medicine and NeonatologyHospital Clinic & Hospital Sant Joan de Deu - University de Barcelona

www.fetalmedicinebarcelona.org

www.medicinafetalbarcelona.org/

Neonatal and Fetal GA-adjusted “normal” weight in the same population

www.medicinafetalbarcelona.org/

SGA Unknown (constitutional + others)

IUGRPlacental insufficiency

ISOLATED FETAL SMALLNESS = POORER PROGNOSISPerinatal and Long-term Outcomes

Exclude extrinsic cause

Exclude primary fetal defect

Poor perinatal outcome + IUFD(Doppler) Signs of adaptation

Perinatal outcome normal - No IUFDNO signs of adaptation

FGR vs. SGA: DIFFERENT MANAGEMENT

www.medicinafetalbarcelona.org/

UtA >p95

CPR <p5(<p15)

EFW CENTILE <3

0%

10%

20%

30%

40%

50%

8%11%

40%

Controls All normal Any abnormal

%

Prognostic criteria of “poor outcome”-SGACS for distress and/or neonatal acidosis

N=509 SGA + 509 controls

Figueras 2013

www.medicinafetalbarcelona.org/

IUGR = abnormal CPR or UtA or EFW<p3early vs late-onset IUGR

Savchev 2013

Red Line EARLY IUGRRed Line LATE IUGR

www.medicinafetalbarcelona.org/

RATIONALE FOR A STAGE-BASED APPROACH TO THE MANAGEMENT OF FGR

PLACENTAL DISEASE HYPOXIA ACIDOSIS SERIOUS INJURY DEATH

cardiac ischemiaDiastolic failure

Systolic cardiac failure

Centralization

Increment placental impedance

cCTG: reduced STV

Diagnostic/chronic markersEarly and Late IUGR

Prognostic/Acute markersEarly IUGR

IVIIIIIIStage fetal deterioration

HIGHMODERATELOWRisks of prematurity

www.medicinafetalbarcelona.org/

1. Identify small fetus

2. FGR vs. SGA

3. Early vs. Late

4. Parameters for fetal follow-up

5. Stage-based management protocol

www.medicinafetalbarcelona.org/

1. Identify small fetus

2. FGR vs. SGA

3. Early vs. Late

4. Parameters for fetal follow-up

5. Stage-based management protocol

Return

www.medicinafetalbarcelona.org/

Neonatal and Fetal GA-adjusted “normal” weight in the same population

Mula 2013, Lobmaier 2013www.medicinafetalbarcelona.org/

IMPROVING DETECTION: THE DEFINITION OF “RESTRICTION”Birthweight inverse relation with perinatal outcome AND brain-cardiac remodelling

!

INTEGRATED 3T SCREENING FOR LATE-PREGNANCY COMPLICATIONSLate-PE, Late-IUGR, Stillbirth

www.medicinafetalbarcelona.org/

1. Identify small fetus

2. FGR vs. SGA

3. Early vs. Late

4. Stage-based management protocol

Return

www.medicinafetalbarcelona.org/

SGA Unknown (constitutional + others)

IUGRPlacental insufficiency

ISOLATED FETAL SMALLNESS = POORER PROGNOSISPerinatal and Long-term Outcomes

Exclude extrinsic cause

Exclude primary fetal defect

Poor perinatal outcome + IUFD(Doppler) Signs of adaptation

Perinatal outcome normal - No IUFDNO signs of adaptation

FGR vs. SGA: DIFFERENT MANAGEMENT

www.medicinafetalbarcelona.org/

Constitutionally small Placental insufficiency Extrinsic cause

Primary fetal defect

SGA FGR

The discovery of UA and hemodynamics of IUGR

FGR = abnormal UA Doppler

20 30 4025 35

0

N  cases

N  cases

UA Doppler +(EARLY-ONSET)

UA Doppler N(LATE-ONSET)

Savchev  2013

www.medicinafetalbarcelona.org/

0

10

20

30

40

Neonatal acidosis CS for distress Abnormal NBAS Any

%

Figueras 2011

SGA: proportion of perinatal adverse outcomes in 376 consecutive cases

www.medicinafetalbarcelona.org/

IMPACT OF NON-DETECTED IUGR ON LATE FETAL MORTALITYBarcelona2005-2010

0%

10%

20%

30%

40%

50%

FGR Unknown Others

25%30%

45%

Classification of stillbirth by relevant condition at birth (ReCoDe): population-based cohort studyGardosi et al. BMJ 2005 and 2013

IUGR as relevant condition identified in 43-60%

Overall stillbirth rate (/ 1000 births) 4.2, but only 2.4 in non-SGA pregnancies, increasing to 9.7 with antenatally detected IUGR and 19.8 in not detected IUGR.

www.medicinafetalbarcelona.org/

UtA >p95

CPR <p5 EFW CENTILE <3

0%

10%

20%

30%

40%

50%

8%11%

40%

Controls All normal Any abnormal

%

Prognostic criteria of “poor outcome”-SGACS for distress and/or neonatal acidosis

N=509 SGA + 509 controls

Figueras 2012

www.medicinafetalbarcelona.org/

Distribution of cases when IUGR = abnormal UA Doppler

Savchev 2013

www.medicinafetalbarcelona.org/

Distribution of cases when IUGR = abnormal CPR or UtA or EFW<p3

Savchev 2013

www.medicinafetalbarcelona.org/

1. Identify small fetus

2. FGR vs. SGA

3. Early vs. Late

4. Stage-based management protocol

Return

www.fetalmedicinebarcelona.org/

IUGR

SGA?

20 30 4025 35

0

3

6 %

IUGR= low CPR or high UtA or EFW<p3 or low PlGF

EARLY IUGR (1%) LATE IUGR (5-7%)

PROBLEM: MANAGEMENT PROBLEM: DIAGNOSIS

Placental disease: high (UA+, PE high) Placental disease: low (UA-, PE low)

Hypoxia ++: systemic CV adaptation Hypoxia +/-: central CV adaptation

Tolerance to hypoxia. Natural history Low tolerance: no natural history

High mortality and morbidity Low mortality but poor long outcome.

32w @diagnosis

www.medicinafetalbarcelona.org/

FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY

PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURYDEATH

cardiac ischemiaDiastolic failure

Systolic cardiac failure

Centralization

Increment placental impedance

growth

MIDDLE CEREBRAL A. <p5

CPR <p5

DUCTUS VENOSUS >p95 and a-

CTG ABNORMAL

UTERINE A. >p95

cCTG: reduced short-term variability

Ao ISTHMUS >p95

UMBILICAL A. >p95

www.medicinafetalbarcelona.org/

FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s)

PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURYDEATH

cardiac ischemiaDiastolic failure

Systolic cardiac failure

growth

UMBILICAL A. >p95

DUCTUS VENOSUS >p95 and a-

CTG / BPP ABNORMAL

Placental injury <30%

mild hypoxiano cardiovascular adaptation

minimal tolerance to hypoxia

MIDDLE CEREBRAL A. <p5

CPR <p5

UTERINE A. >p95

Ao ISTHMUS >p95

Centralization

Increment placental impedance

www.fetalmedicinebarcelona.org/

IUGR

SGA?

20 30 4025 35

0

3

6 %

IUGR= low CPR or high UtA or EFW<p3 or low PlGF

EARLY IUGR (1%) LATE IUGR (5-7%)

PROBLEM: MANAGEMENT PROBLEM: DIAGNOSIS

Placental disease: high (UA+, PE high) Placental disease: low (UA-, PE low)

Hypoxia ++: systemic CV adaptation Hypoxia +/-: central CV adaptation

Tolerance to hypoxia. Natural history Low tolerance: no natural history

High mortality and morbidity Low mortality but poor long outcome.

32w @diagnosis

www.medicinafetalbarcelona.org/

1. Identify small fetus

2. FGR vs. SGA

3. Early vs. Late

4. Parameters for fetal follow up

4. Stage-based management protocol

Return

umbilical arterynormal and anormal hemodynamics

DS

Cardiac pump normal function

Cardiac pump abnormal function

Placental  status

<30%

placenta    +  cardiac  ischemia

middle cerebral arterynormal and abnormalhemodynamics

[marked vasodilation]

[normal waveform]

[mild vasodilation]

Normal oxygenation

hypoxia

www.medicinafetalbarcelona.org/

30 % venous return

REFLECTS DIASTOLIC PRESSURE IN RIGHT (AND LEFT) HEART

ductus venosusnormal and abnormal hemodynamics

Venous vessel: pulsation due to retrograde pressure

S DA

ductus venosusnormal and abnormal hemodynamics

compliance right chambers: effect sobre

on venous return

DS A

P

P

P

P

Myocardial ischemia

compliance

no

Perinatal           >90%   30-­‐40%   <10%Mortality

www.medicinafetalbarcelona.org/

<26 26-28 >28

Baschat  2003Hecher  2003  Grivell  2009Cruz-­‐Lemini  2012

Early-onset IUGRPROBLEM #1: MORTALITY

DVa  (rev)

Yes No

60%

19%

cCTG-­‐STV<3  ms

Pathological  CGT

Perinatal           >90%   30-­‐40%   <10%Mortality

www.medicinafetalbarcelona.org/

<29 29-32 >32.0

Fouron  2004Del  Rio  2008Cruz-­‐MarOnez  2012

Early-onset IUGRPROBLEM #2: (NEUROLOGICAL) MORBIDITY

0

15

30

45

60

(%)

ControlsIUGR antegrade AoIIUGR retrograde AoI

ControlsIUGR DV<5 z-scoreIUGR DV>5 z-score

**

Brain US anomalies in 30w IUGR

www.medicinafetalbarcelona.org/

1. Identify small fetus

2. FGR vs. SGA

3. Early vs. Late

4. Parameters for fetal follow up

5. Stage-based management protocol

Return

www.medicinafetalbarcelona.org/

IUGR = abnormal CPR or UtA or EFW<p3

Savchev 2013

Red Line EARLY IUGRRed Line LATE IUGR

www.medicinafetalbarcelona.org/

RATIONALE FOR A STAGE-BASED APPROACH TO THE MANAGEMENT OF FGR

PLACENTAL DISEASE HYPOXIA ACIDOSIS SERIOUS INJURY DEATH

cardiac ischemiaDiastolic failure

Systolic cardiac failure

Centralization

Increment placental impedance

cCTG: reduced STV

Diagnostic/chronic markersEarly and Late IUGR

Prognostic/Acute markersEarly IUGR

IVIIIIIIStage fetal deterioration

HIGHMODERATELOWRisks of prematurity

www.medicinafetalbarcelona.org/

Protocol IUGRFirst step: UtA + CPR + EFW = SGA or IUGR

CPR<p5

Ut A >p95

MCA<p5

DV (a rev)

CGT decelerations of reduced short-term

variability

REDV DV >p95

I low EFW (<p3) or mild placental resistance / redistribution

III Severe placental resistance / redistribution

III Severe hemodynamic adaptation - Low suspicion acidosis

IV High suspicion of acidosis - High risk of death

AEDV AoI >p95

Delivery Any  Ome 30 34 37

Mort.         >90%   50%   <10%Morb.     >90%     50%

www.medicinafetalbarcelona.org/

<26w 26-28 28-32 32-34 34-37

CriteriaDV(a-­‐)

cCTG  abn.CTG  dec.

DV>p95UV  puls  REDV

(a)  AEDV(b)  AoI>95 CPR>p95

UtA>p95MCA<p5

EFW<p3

Stage IV III II I

Mode CS CS CS  or  LI LI

IUGRManagement protocol according to severity stages

Follow-­‐up Hours/Daily 1-­‐2  d 2/w 1/w

www.medicinafetalbarcelona.org/

The main goal in FGR is identification

Small fetus (EFW<p10) must be divided in: FGR (placenta, poor perinatal and long-term outcome)

SGA (we don’t know, perinatal outcome N, poor long term)

Early and late-onset FGR (GA 32s) represent two distinct phenotypes of the same disease

Clinically, a single stage-based protocol allows optimizing decisions in all cases